$NNE Balance Sheet | Understand Stock

$NNE

$12.40 +$0.06 (0.49%) Pre-market

Financial Statements

In millions of USD, except per-share amounts

	Q3 FY2026 As of Jun 30, 2026	Q2 FY2026 As of Mar 31, 2026	Q1 FY2026 As of Dec 31, 2025	Q4 FY2025 As of Sep 30, 2025	Q3 FY2025 As of Jun 30, 2025	Q2 FY2025 As of Mar 31, 2025	Q1 FY2025 As of Dec 31, 2024	Q4 FY2024 As of Sep 30, 2024	Q3 FY2024 As of Jun 30, 2024	Q2 FY2024 As of Mar 31, 2024
ASSETS
Current assets:
Cash
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Prepaid expenses
Prepaid and other current assets
Deposits, current
Marketable securities, at fair value
Total current assets
Deferred offering costs
Deposits, non-current
Property, plant and equipment, net
Right-of-use assets
Long-term investments, related party
Goodwill
Intangible assets
In-process research and development
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Due to related parties
Related Party
Total due to related parties
Lease liabilities, current
Deferred acquisition consideration, current
Contingent consideration
Total current liabilities
Total lease liabilities, less current portion
Deferred acquisition consideration, non-current
Total liabilities
Stockholders’ equity
Common stock, $0.0001 par value; 275,000,000 authorized as of June 30, 2026 and September 30, 2025; 53,698,146 and 41,738,358 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments